Someone bet big in the options market that Puma Biotechnology would be a winner in the days before a positive drug trial sent its stock soaring.» Read More
Charlie Bobrinskoy, Ariel investment vice chairman, waves the red flag on tech names that are overvalued.
CNBC's Meg Tirrell reports Allergan posted Q2 results that beat on earnings and sales, as the company announced its restructuring plans, which may include an acquisition of its own.
Pershing Square's Bill Ackman says he'll show evidence that Herbalife is a massive fraud.
Herb Greenberg, CNBC contributor, shares his thoughts on Bill Ackman's comments that Herbalife is a fraud. Let's not forget this is about the business model, says Greenberg.
Bill Ackman, Pershing Square, explains why he is not upping his bid for Allergan. The market clearly thinks the chance of Valeant buying Allergan has gone up, says Ackman.
CNBC's Michelle Caruso-Cabrera reports on the latest international developments in Ukraine after President Obama says he's considering increasing the costs for Russia's behavior.
The FMHR traders reveal their final trades of the hour, including the play on shares of Nimble Storage and Ingersoll-Rand.
The "Fast Money" traders share their final trades of the day.
Data from the biotech sector appear to refute Janet Yellen's remarks about stock valuations, ISI Group's Mark Schoenbaum says.
The FMHR traders share their trades on market uncertainty.
Chad Sweet, Chertoff Group co-founder & CEO, explains why it's time for the U.S. and Europe to ratchet up sanctions.
Fast Money's Jon Najarian is seeing unusual trading activity in shares of Melco Crown Entertainment.
The stakes are high for Europe, says President Obama, remarking on the missile attack on Malaysia Airlines Flight MH17.
CNBC's John Harwood provides insight on President Obama's remarks on the crash of Flight MH17. And Michelle Caruso-Cabrera weighs in on where the investigation will likely go from here.
Regardless of nationality, it is a heart-breaking event, says President Obama. Also Obama comments on Russian sanctions and its impact on global economies.
CNBC's Phil LeBeau reports the latest details on the crash of Flight MH17.
The Futures Now team discusses what's driving the drop in the precious metal and whether the fear trade is over.
Mark Schoenbaum, ISI Group, explains why his views differ from Janet Yellen on whether the biotech sector is forming a bubble.
The FMHR traders reveal their final trades of the hour.
News of Malaysian Air 17's crash in Eastern Ukraine sent a ripple effect through the markets, says "Fast Money" trader Jon Najarian.